The Journal of the American Academy of Dermatology published new guidance on the 2026 Ebola virus disease outbreak on October 9, 2026, prepared by the American Academy of Dermatology's Emerging Disease Task Force under the title "2026 Ebola Virus Disease Outbreak: What Dermatologists Should Know."

The article, available online as of October 9, 2026, comes from a 12-author writing group led by Misha Rosenbach of the University of Pennsylvania, with co-authors Tanya Boghosian, Rachel Granovsky, Sarah Rimmer, Yvonne Chiu, Boni E. Elewski, David Rosmarin, Jordan Said, John Christopher Trinidad, Lida Zheng, and Carolyn Goh. All authors are credited to the AAD Emerging Disease Task Force.

Why does an Ebola outbreak concern dermatologists?

Viral hemorrhagic fevers such as Ebola virus disease can present with mucocutaneous findings early in illness, and the task force's title signals that dermatologists may be among the first clinicians to encounter suspicious presentations. The 2026 outbreak prompted the AAD to convene its standing Emerging Disease Task Force — the same mechanism the Academy has used to rapidly disseminate clinical guidance during prior emerging infections — and to publish in JAAD rather than through a standalone bulletin, placing the guidance in the peer-reviewed literature.

What does the publication contain?

The paper takes the form of a task force review aimed at practicing dermatologists, addressing what the specialty should know about Ebola virus disease in the context of the current outbreak. The author roster spans academic dermatology and infectious-disease-adjacent expertise, with Elewski, Rosmarin, Chiu, Goh, Trinidad, and Rosenbach representing institutions with established emerging-infection response programs.

How should clinicians use it?

Derm Field readers managing patients with fever and unexplained rash or mucosal findings, or those drafting triage and infection-control protocols for their practices, can access the article online via JAAD as of October 9, 2026. Given the speed of outbreak epidemiology, clinicians should expect the task force's recommendations to be updated as the 2026 situation evolves.